Cecilia Galli

Dr. Cecilia Galli

Sapienza Univeristy of Rome
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
VNValentina Del Negro
Valentina Del Negro
NANatalia Aleksa
Natalia Aleksa
CGCecilia Galli
Cecilia Galli
ECEnrico Ciminello
Enrico Ciminello
Martina DermeMartina Derme
Martina Derme
Maria Grazia PiccioniMaria Grazia Piccioni
Maria Grazia Piccioni
The objective of this study was to evaluate a novel ultrasonographic scoring system for the diagnosis of PAS and the prediction of maternal and neonatal outcomes. In this retrospective study, 138 patients with at least one previous caesarean section (CS) and placenta previa were included. They were divided into four groups ranging from Group 0 (Non PAS) to Group 3 (Placenta Percreta) according to the histological or surgical confirmation. Their ultrasound examinations during pregnancy were reviewed according to the nine different ultrasound signs reported by the European Working Group on Abnormally Invasive Placenta. For each parameter, 0 to 2 points were assigned. The sum of the points reflects the severity of PAS with a maximum score of 20. The scoring system revealed good performances in evaluation metrics, with an overall accuracy of 94%. In addition to this, patients’ characteristics and surgical and neonatal outcomes were analyzed with an evidence of higher incidence of complications in severe forms. Our study suggests that antenatal ultrasonographic diagnosis of PAS is feasible with sufficient level of accuracy. This will be important in identifying high-risk patients and implementing preventive strategy.

1 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
LMLucia Merlino
Lucia Merlino
TLTiti Luca
Titi Luca
FPFederica Del Prete
Federica Del Prete
CGCecilia Galli
Cecilia Galli
CMChiara Mandosi
Chiara Mandosi
Maria Grazia PiccioniMaria Grazia Piccioni
Maria Grazia Piccioni
Breast cancer has the greatest epidemiological impact in women. Opioids represent the most prescribed analgesics, both in surgical time and in immediate postoperative period, as well as in chronic pain management as palliative care. We made a systematic review analyzing the literature’s evidence about the safety of opioids in breast cancer treatment, focusing our attention on the link between opioid administration and increased relapses. The research has been conducted using the PubMed database. Preclinical studies, retrospective and prospective clinical studies, review articles and original articles were analyzed. In the literature, there are several preclinical in vitro and in vivo studies, suggesting a possible linkage between opioids administration and progression of cancer disease. Nevertheless, these results are not confirmed by clinical studies. The most recent evidence reassures the safety of opioids during surgical time as analgesic associated with anesthetics drugs, during postoperative period for optimal cancer-related pain management and in chronic use. Currently, there is controversial evidence suggesting a possible impact of opioids on breast cancer progression, but to date, it remains an unresolved issue. Although there is no conclusive evidence, we hope to arouse interest in the scientific community to always ensure the best standards of care for these patients.

Maria Grazia PorporaMaria Grazia Porpora
Maria Grazia Porpora
LMLucia Merlino
Lucia Merlino
LMluisa masciullo
luisa masciullo
RDRossella D’alisa
Rossella D’alisa
GBGabriella Brandolino
Gabriella Brandolino
Maria Grazia PiccioniMaria Grazia Piccioni
Maria Grazia Piccioni
Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection is a major health threat. Pregnancy can lead to an increased susceptibility to viral infections. Although chest computed tomography (CT) represents the gold standard for the diagnosis of SARS-CoV-2 pneumonia, lung ultrasound (LUS) could be a valid alternative in pregnancy. The objectives of this prospective study were to assess the role of LUS in the diagnosis of lung involvement and in helping the physicians in the management of affected patients. Thirty pregnant women with SARS-CoV-2 infection were admitted at the obstetrical ward of our Hospital. Mean age was 31.2 years, mean gestational age 33.8 weeks. Several LUS were performed during hospitalization. The management of the patients was decided according to the LUS score and the clinical conditions. Mean gestational age at delivery was at 37.7 weeks, preterm birth was induced in 20% of cases for a worsening of the clinical conditions. No neonatal complications occurred. In 9 cases with a high LUS score, a chest CT was performed after delivery. CT confirmed the results of LUS, showing a significant positive correlation between the two techniques. LUS seems a safe alternative to CT in pregnancy and may help in the management of these patients.

5 April 2023 in Open Journal of Clinical and Medical Case Reports
Verified
Journal Article
Open access
CGCecilia Galli
Cecilia Galli
Open journal of clinical and medical case reports